BFM
INBX icon

Boothbay Fund Management’s Inhibrx INBX Stock Holding History

Boothbay Fund Management’s Portfolio INBX Stock Details INBX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-92,009
Closed -$7.27M – 2259
2025
Q4 		$7.27M Buy
92,009
+13,197
+17% +$899K 0.11% 199
2025
Q3 		$2.65M Buy
78,812
+50,582
+179% +$1.25M 0.04% 504
2025
Q2 		$403K Hold
28,230
– – 0.01% 992
2025
Q1 		$395K Hold
28,230
– – 0.01% 953
2024
Q4 		$435K Sell
28,230
-1
-0% -$15 0.01% 930
2024
Q3 		$442K Sell
28,231
-52,881
-65% -$743K 0.01% 1037
2024
Q2 		$1.15M Buy
+81,112
New +$1.27M 0.03% 672

Other funds holding INBX

PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
S
Sanofi Paris, France $336M AUM 126.85% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $94.2B AUM 21.24% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Boothbay Fund Management's INBX Position: Q1 2026 in Review

Boothbay Fund Management sold out of Inhibrx (INBX) in Q1 2026, closing a stake of 92,009 shares — an estimated $7.27M sold.

Boothbay Fund Management first reported a position in INBX in Q2 2024 and held it in 7 quarters. The position peaked at $7.27M in Q4 2025. 135 funds tracked by Wall St. Rank hold INBX as of Q1 2026.

  • Boothbay Fund Management reported no remaining Inhibrx position as of Q1 2026 after selling out during the quarter.
  • Boothbay Fund Management sold 92,009 Inhibrx shares in Q1 2026, an estimated $7.27M.
  • Boothbay Fund Management first reported a position in Inhibrx in Q2 2024 and held it in 7 quarters.
  • Boothbay Fund Management's Inhibrx position peaked at $7.27M in Q4 2025.
  • 135 funds tracked by Wall St. Rank held Inhibrx as of Q1 2026.

Based on Boothbay Fund Management's 13F filing for Q1 2026, filed 15 May 2026.